Merck (MRK) Withdraws European MAA for Rdaforolimus

November 29, 2012 8:04 AM EST Send to a Friend
Merck (NYSE: MRK) has formally notified the European Medicines Agency (EMA) of Merck's decision to withdraw the Marketing Authorisation Application ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login